🖼

FIGURE 2 — Glymphatic System Dysfunction in Central Nervous System Diseases.

active
paper figure Created: 2026-04-21T18:29:40 By: paper_figures_tool Quality: 50% 🔗 External ID: paper-fig-paper-6a75f22ee076-2
FIGURE 2 — Glymphatic System Dysfunction in Central Nervous System Diseases.
FIGURE 2Figure 2
Glymphatic Dysfunction in Neurodegeneration, Impaired glymphatic clearance leads to accumulation of Amyloid‐β, Tau, and α‐synuclein in Alzheimer's disease and Parkinson's disease. Factors like aging, sleep disorders, and obesity worsen this dysfunction, promoting protein aggregation, neuroinflammation, and dementia. Created in https://BioRender.com .
PubMed: paper-6a75f22ee076
Metadata
pmidpaper-6a75f22ee076
captionGlymphatic Dysfunction in Neurodegeneration, Impaired glymphatic clearance leads to accumulation of Amyloid‐β, Tau, and α‐synuclein in Alzheimer's disease and Parkinson's disease. Factors like aging,
image_urlhttps://www.ebi.ac.uk/europepmc/articles/PMC12965907/bin/CNS-32-e70810-g003.jpg
paper_titleGlymphatic System Dysfunction in Central Nervous System Diseases.
figure_labelFIGURE 2
figure_number2
_schema_version1
source_strategypmc_api
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
View full evidence profile →
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.